Cargando…
Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data
BACKGROUND: Several randomized controlled trials have shown that adjuvant immunotherapy with autologous cytokine-induced killer (CIK) cells prolongs recurrence-free survival (RFS) after curative treatment for hepatocellular carcinoma (HCC). We investigated the efficacy of adjuvant immunotherapy with...
Autores principales: | Yoon, Jun Sik, Song, Byeong Geun, Lee, Jeong-Hoon, Lee, Hyo Young, Kim, Sun Woong, Chang, Young, Lee, Yun Bin, Cho, Eun Ju, Yu, Su Jong, Sinn, Dong Hyun, Kim, Yoon Jun, Lee, Joon Hyeok, Yoon, Jung-Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543598/ https://www.ncbi.nlm.nih.gov/pubmed/31151419 http://dx.doi.org/10.1186/s12885-019-5740-z |
Ejemplares similares
-
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up
por: Lee, Jeong-Hoon, et al.
Publicado: (2018) -
Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Chung, Sung Won, et al.
Publicado: (2021) -
A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma
por: Lee, Jeong-Hoon, et al.
Publicado: (2015) -
Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study
por: Yoon, Jun Sik, et al.
Publicado: (2019) -
Short-term and long-term outcomes of laparoscopic vs open ileocolic resection in patients with Crohn's disease: Propensity-score matching analysis
por: Pak, Shin Jeong, et al.
Publicado: (2021)